Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
NEWARK, Del. — Wilmington PharmaTech ("WPT"), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today announced a majority investment by Curewell C
(Financial Post, 2025-10-21T12:12:15Z)